Trident Lifeline Ltd
Trident Lifeline Ltd Live Price Chart
Performance
| Previous Close | ₹ 428.15 |
| High | ₹ 427 |
| Volume | 8400 |
| 52W Range | ₹ 229.95 - ₹ 442 |
| Open | ₹ 415.4 |
| Low | ₹ 415.4 |
| Market Cap | ₹ 467.7 Cr |
Trident Lifeline Ltd Technicals
| 20 Day | ₹ 413.253 |
| 50 Day | ₹ 380.402 |
| 100 Day | ₹ 342.770 |
| 200 Day | ₹ 313.310 |
| 20 Day | ₹ 416.523 |
| 50 Day | ₹ 377.303 |
| 100 Day | ₹ 320.794 |
| 200 Day | ₹ 289.991 |
Trident Lifeline Ltd Fundamentals
| ROCE | 20.811 |
| P/E Ratio | 23.720 |
| P/B Ratio | 4.510 |
| Industry P/E | 4.510 |
| Debt to Equity | 52.262 |
| ROE | 19.136 |
| EPS | 17.750 |
| Dividend Yield | 0.000 |
| Book Value | 93.313 |
| Face Value | 10.000 |
Trident Lifeline Ltd Financials
| Particulars | Y202603 | Y202503 | Y202403 | Y202303 | Y202203 |
|---|---|---|---|---|---|
| Total Revenue | 106.0706 | 70.9399 | 46.8552 | 32.8457 | 22.3715 |
| Total Expenses | 81.0914 | 53.0341 | 37.0562 | 26.2719 | 19.3879 |
| Profit After Tax | 18.0927 | 13.0514 | 7.0434 | 6.012 | 3.9477 |
Trident Lifeline Ltd Shareholding Pattern
| Promoter Holdings | 62.536 % |
| FIIs | 1.157 % |
| DIIs | 0.210 % |
| MutualFund | 0.000 % |
| Retail | 24.679 % |
| Others - | 11.418 % |
About Trident Lifeline Ltd
Trident Lifeline Limited was originally incorporated as Private Limited Company as 'Trident Lifeline Private Limited' on January 09, 2014. Subsequently, Company converted into a Public Limited and the name of Company was changed to 'Trident Lifeline Limited' on June 10, 2022. The Company established itself as a growing force in the pharmaceutical industry, distinguished by a focus on innovation and disciplined expansion. It operates a hybrid business model that combines its own and contract manufacturing with direct exports, allowing it to scale efficiently and serve diverse geographies including India, Africa, Latin America, the CIS region and Asia. Its product portfolio spans key therapeutic areas including anti-bacterial, anti-diabetic, anti-hypertensive, anti-lipidemic, proton pump inhibitor and nutraceutical categories, alongside cosmetic and herbal products through its subsidiaries. The Company deal in Capsules, Tablets, Liquid Ointment, Gel, Ice Gel, Mouthwash, Paste, Solution, Suspension, Drypowders and Toothpaste. The product portfolio comprises of drugs like Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steriodal anti-inflammatory drug (NSAIDS). Company made an Initial Public Offering (IPO) of 34,99,200 Equity Shares of face value Rs 10/- each by raising ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 38.59 +1.83 (+4.98%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 507.00 -0.5 (-0.1%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 6,039.00 -392.2 (-6.1%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 673.20 +32.05 (+5%) |
| Abbott India Ltd Pharmaceuticals | ₹ 26,370.00 -233.6 (-0.88%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,393.00 -17 (-1.21%) |
FAQs on Trident Lifeline Ltd
1. Can I buy Trident Lifeline Ltd from PL Capital? ›
2. Does Trident Lifeline Ltd pay dividends? ›
3. What is the current share price of Trident Lifeline Ltd ? ›
4. What is the 52-week high and low of Trident Lifeline Ltd ? ›
5. What is the market capitalisation of Trident Lifeline Ltd? ›
6. What is the current P/E ratio of Trident Lifeline Ltd? ›
7. What is the current P/B ratio of Trident Lifeline Ltd? ›
8. What is the shareholding pattern of Trident Lifeline Ltd? ›
9. What is the 1-year return of Trident Lifeline Ltd? ›
Start SIP in Trident Lifeline Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
